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remarks onour study. To clarify,Dr. Saadat raised concernswith
respect to genotyping errors based on the observed deviation
from Hardy–Weinberg equilibrium for this particular polymor-
phism in our trial. Genotyping error is indeed one of the many
possible sources of Hardy–Weinberg disequilibrium. To exclude
this possibility and because the D allele in heterozygous samples
is preferentially amplified, as reported in our publication [2], each
sample that found to have the DD genotype was subjected to a
second, independent PCR amplification with a primer pair that
recognizes an insertion-specific sequence,with identicalPCRcon-
ditions except for an annealing temperature of 67 C. The reac-
tion yields a 335-bp amplicon only in the presence of an I allele
and no product in samples homozygous for DD. This procedure
correctly identified sampleswith theDIgenotype that aremisclas-
sified as DD with the insertion-spanning primers, which we con-
cern it as an insuring test of our results.
Although testing for Hardy–Weinberg equilibrium is used
as some quality-control measure, particularly in case-control
gene association studies, it cannot be used to detect genotyping
error [3,4]. Genotyping errors are generally small and do not
generate sufficient deviations from Hardy–Weinberg equilib-
rium to be detected. In the case of a reduced number of
observed heterozygous patients, as may occur in the presence
of poor amplification of one of the alleles, large sample sizes
are necessary to detect deviations from Hardy–Weinberg equi-
librium. Therefore, testing for Hardy–Weinberg equilibrium is
an unreliable tool to identify genotyping errors. Conversely,
the presence of Hardy–Weinberg equilibrium does not rule
out that genotyping errors might have occurred. Hence, it
seems unlikely that genotyping error is the source of the
Hardy–Weinberg disequilibrium observed in our study.
Because approximately 10% of all genotype–phenotype associ-
ation studies show deviation from Hardy–Weinberg equilib-
rium, the results of our trial cannot be considered
‘‘abnormal’’ [5]. A selection bias (population stratification)
may have occurred because of inclusion and exclusion criteria
of this randomized trial.Even when deviations from HWE are detected for marker
loci, without additional experimentation it is not possible to
unequivocally implicate genotyping error as the cause. The
power and sample sizes necessary to detect deviations from
HWE for single-nucleotide polymorphism (SNP) data are
examined for a variety of genotyping errors and pseudo-SNP
models. For the majority of genotyping models examined,
the power is poor to detect deviations from HWE. For
example, for 1000 controls, if an allele with a frequency of
0.1 fails to amplify for 28% of the heterozygous genotypes
producing a sample error rate of 0.05, the power is 0.51 to
detect a deviation from HWE at an alpha level of 0.05. On
the other hand, the detection of deviations from HWE for
pseudo-SNPs for the majority of models examined produces
a power of >0.8 for sample sizes as small as 50 individuals [4].
Therefore, testing for Hardy–Weinberg equilibrium is an
unreliable tool to identify genotyping errors. Conversely, the
presence of Hardy–Weinberg equilibrium does not rule out
that genotyping errors might have occurred. Measures of
departure from HWE may be useful for detecting genotyping
error, but this needs to be confirmed in other real datasets [6].
Of note, Hardy–Weinberg disequilibrium that is caused by
most interesting biologic phenomena typically results in excess
homozygosity, as observed in our study [2].
We noticed a high diversity in different Egyptian studies of
the ACE I/D polymorphism papers mentioned by Dr. Saadat
and also on other Egyptian studies, for example, as regard D
allele frequency it was 30.7% and 38.6% in references [7]
and [8] respectively, but it was 48.8% and 53% in references
[9] and [10] respectively, while it was 70.6%, 71.2%, 83%
and 91.3% in references [11–13] and [14] respectively. From
the previous findings, we conclude that there is a serious need
of more studies of the Egyptian population on larger scales.
However, we agree with Dr. Saadat that violation of Hardy–
Weinberg equilibrium in our study population implies a
selected rather than a random sample, invalidating direct com-
parisons with other populations. Therefore, we share his view
that our results should be regarded with caution. Our findings
should be confirmed in future prospective larger-scale clinical
86 Editorialtrials, specifically designed and adequately powered to detect
genotype-specific differences in Alzheimer patients.
For the issue concerning the plasma ACE activity, for the
first insight into the results, we also thought there will be a sig-
nificant difference of the activity between AD patient groups,
but statistics revealed no significant difference which could be
referred to the number of AD patients having the II genotype.
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